Market Cap 230.21M
Revenue (ttm) 194.06M
Net Income (ttm) 14.35M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 7.39%
Debt to Equity Ratio 0.00
Volume 550,300
Avg Vol 990,560
Day's Range N/A - N/A
Shares Out 48.36M
Stochastic %K 42%
Beta 1.99
Analysts Strong Sell
Price Target $9.88

Company Profile

LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States. It offers telehealth platform comprising Rex MD, a men's telehealth platform that provides virtual diagnosis, treatment, and prescription medications for men's health conditions, including erectile dysfunction, premature ejaculation, hair loss, insomnia, weight loss, and performance anxiety; and ShapiroMD that provides vi...

Industry: Health Information Services
Sector: Healthcare
Phone: 866 351 5907
Website: lifemd.com
Address:
236 Fifth Avenue, Suite 400, New York, United States
DailyWatcher_
DailyWatcher_ Jul. 13 at 11:31 AM
$HIMS bulls: which catalyst are you most excited about right now? A) FDA peptide decision B) Next earnings report and forward guidance C) Continued international expansion + Hers platform growth Also watching $LFMD, $DOCS, and $AMWL as digital healthcare continues to evolve and investor attention shifts across the sector. Drop your answer below 👇 I share what I'm watching in real time. Stay notified. Visit my profile for more market insights, trade ideas, and high-conviction stock setups.
0 · Reply
ClarissaLove
ClarissaLove Jul. 10 at 4:25 AM
$LFMD Afterhours volume = 6 shares
1 · Reply
pleiades108
pleiades108 Jul. 9 at 9:25 PM
$LFMD Nice gap up after market. Let's see if it holds.
0 · Reply
GuruChartist
GuruChartist Jul. 9 at 3:51 PM
$LFMD It is crucial for LFMD to show strong 2Q results.
1 · Reply
BillionerOfKing
BillionerOfKing Jul. 8 at 11:58 PM
$LFMD Current Stock Price: $4.68 Contracts to trade: $5.0 LFMD Jul 17 2026 Call Entry: $0.10 Exit: $0.17 ROI: 71% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ClarissaLove
ClarissaLove Jul. 8 at 5:09 PM
0 · Reply
Alex1965
Alex1965 Jul. 8 at 3:09 PM
$LFMD FWIW. Long LFMD
0 · Reply
Alex1965
Alex1965 Jul. 8 at 3:06 PM
$LFMD RexMD has over 200K subscribers.
0 · Reply
StockScanners
StockScanners Jul. 4 at 5:11 PM
$LFMD keep watch if this holds above 4.77
0 · Reply
Alex1965
Alex1965 Jul. 2 at 8:16 PM
$LFMD The stock got dumped for days and under $4.00 to July 1st. Now why ??? Think smart money, funds.... Nonsense and baseless comments like this one confuse the less savvy retail investors... Beware !!! "...this stock feels more like it is being bleed to death than actually trying to grow and become profitable now." All LFMD's fundamental metrics are all fine and historic best except revenue growth. And that too will improve markedly over the next 18 months starting in Q3 this year. Remember to perform your own DD. PS New exclusive deals getting signed before calendar year ends. a Stronger moat and a very different business model from the rest of the peers.
0 · Reply
Latest News on LFMD
LifeMD appoints Umesh Sripad as chief technology officer

2026-06-01T14:34:47.000Z - 6 weeks ago

LifeMD appoints Umesh Sripad as chief technology officer


LifeMD Appoints Umesh Sripad as Chief Technology Officer

Jun 1, 2026, 8:05 AM EDT - 6 weeks ago

LifeMD Appoints Umesh Sripad as Chief Technology Officer

LFMDP


LifeMD Transcript: 16th Annual LD Micro Invitational Conference

May 19, 2026, 12:00 PM EDT - 2 months ago

LifeMD Transcript: 16th Annual LD Micro Invitational Conference


LifeMD to Participate in Upcoming Investor Conferences

May 15, 2026, 8:00 AM EDT - 2 months ago

LifeMD to Participate in Upcoming Investor Conferences

LFMDP


LifeMD Slides: Investor presentation

May 7, 2026, 7:00 AM EDT - 2 months ago

LifeMD Slides: Investor presentation


LifeMD reports Q1 EPS (20c), consensus (12c)

2026-05-07T00:47:06.000Z - 2 months ago

LifeMD reports Q1 EPS (20c), consensus (12c)


LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M

2026-05-07T00:46:21.000Z - 2 months ago

LifeMD sees Q2 revenue $47M-$50M, consensus $53.74M


LifeMD backs FY26 revenue view $220M-$230M, consensus $223.59M

2026-05-07T00:45:57.000Z - 2 months ago

LifeMD backs FY26 revenue view $220M-$230M, consensus $223.59M


LifeMD Earnings Call Transcript: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

LifeMD Earnings Call Transcript: Q1 2026


LifeMD Earnings release: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

LifeMD Earnings release: Q1 2026


LifeMD Slides: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

LifeMD Slides: Q1 2026


LifeMD Quarterly report: Q1 2026

May 6, 2026, 4:30 PM EDT - 2 months ago

LifeMD Quarterly report: Q1 2026


LifeMD Reports First Quarter 2026 Results

May 6, 2026, 4:05 PM EDT - 2 months ago

LifeMD Reports First Quarter 2026 Results


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

LifeMD Proxy statement: Proxy filing


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

LifeMD Proxy statement: Proxy filing


LifeMD Proxy statement: Proxy filing

Apr 30, 2026, 8:00 AM EDT - 2 months ago

LifeMD Proxy statement: Proxy filing


LifeMD management to meet with BTIG

2026-04-24T17:05:27.000Z - 2 months ago

LifeMD management to meet with BTIG


LifeMD now offering Foundayo from Eli Lilly

2026-04-10T12:26:19.000Z - 3 months ago

LifeMD now offering Foundayo from Eli Lilly

LLY


LifeMD announces launch of Wegovy subscription program

2026-03-31T14:25:15.000Z - 3 months ago

LifeMD announces launch of Wegovy subscription program

NVO


LifeMD management to meet virtually with B. Riley

2026-03-17T15:41:34.000Z - 4 months ago

LifeMD management to meet virtually with B. Riley


LifeMD upgraded to Outperform from Neutral at Mizuho

2026-03-16T08:40:05.000Z - 4 months ago

LifeMD upgraded to Outperform from Neutral at Mizuho


LifeMD price target raised to $10 from $8 at Freedom Capital

2026-03-12T14:11:07.000Z - 4 months ago

LifeMD price target raised to $10 from $8 at Freedom Capital


LifeMD price target raised to $10 from $9 at H.C. Wainwright

2026-03-11T10:15:39.000Z - 4 months ago

LifeMD price target raised to $10 from $9 at H.C. Wainwright


LifeMD Earnings Call Transcript: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

LifeMD Earnings Call Transcript: Q4 2025


LifeMD Annual report: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

LifeMD Annual report: Q4 2025


LifeMD Earnings release: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

LifeMD Earnings release: Q4 2025


LifeMD Slides: Q4 2025

Mar 9, 2026, 4:30 PM EDT - 4 months ago

LifeMD Slides: Q4 2025


LifeMD reports Q4 EPS 41c, consensus 3c

2026-03-09T20:21:55.000Z - 4 months ago

LifeMD reports Q4 EPS 41c, consensus 3c


LifeMD sees Q1 revenue $48M-$49M, consensus $45.61M

2026-03-09T20:21:26.000Z - 4 months ago

LifeMD sees Q1 revenue $48M-$49M, consensus $45.61M


LifeMD sees FY26 revenue $220M-$230M, consensus $222.64M

2026-03-09T20:20:41.000Z - 4 months ago

LifeMD sees FY26 revenue $220M-$230M, consensus $222.64M


LifeMD Reports Fourth Quarter and Full Year 2025 Results

Mar 9, 2026, 4:05 PM EDT - 4 months ago

LifeMD Reports Fourth Quarter and Full Year 2025 Results

LFMDP


LifeMD closes $50M revolving credit facility

2026-01-06T13:47:34.000Z - 6 months ago

LifeMD closes $50M revolving credit facility


LifeMD Earnings Call Transcript: Q3 2025

Nov 17, 2025, 4:30 PM EST - 8 months ago

LifeMD Earnings Call Transcript: Q3 2025


LifeMD Quarterly report: Q3 2025

Nov 17, 2025, 4:30 PM EST - 8 months ago

LifeMD Quarterly report: Q3 2025


LifeMD Earnings release: Q3 2025

Nov 17, 2025, 4:30 PM EST - 8 months ago

LifeMD Earnings release: Q3 2025


LifeMD Slides: Q3 2025

Nov 17, 2025, 4:30 PM EST - 8 months ago

LifeMD Slides: Q3 2025


LifeMD Reports Third Quarter 2025 Results

Nov 17, 2025, 4:05 PM EST - 8 months ago

LifeMD Reports Third Quarter 2025 Results

LFMDP


LifeMD to Participate in the BTIG Digital Health Forum

Nov 10, 2025, 8:00 AM EST - 8 months ago

LifeMD to Participate in the BTIG Digital Health Forum

LFMDP


DailyWatcher_
DailyWatcher_ Jul. 13 at 11:31 AM
$HIMS bulls: which catalyst are you most excited about right now? A) FDA peptide decision B) Next earnings report and forward guidance C) Continued international expansion + Hers platform growth Also watching $LFMD, $DOCS, and $AMWL as digital healthcare continues to evolve and investor attention shifts across the sector. Drop your answer below 👇 I share what I'm watching in real time. Stay notified. Visit my profile for more market insights, trade ideas, and high-conviction stock setups.
0 · Reply
ClarissaLove
ClarissaLove Jul. 10 at 4:25 AM
$LFMD Afterhours volume = 6 shares
1 · Reply
pleiades108
pleiades108 Jul. 9 at 9:25 PM
$LFMD Nice gap up after market. Let's see if it holds.
0 · Reply
GuruChartist
GuruChartist Jul. 9 at 3:51 PM
$LFMD It is crucial for LFMD to show strong 2Q results.
1 · Reply
BillionerOfKing
BillionerOfKing Jul. 8 at 11:58 PM
$LFMD Current Stock Price: $4.68 Contracts to trade: $5.0 LFMD Jul 17 2026 Call Entry: $0.10 Exit: $0.17 ROI: 71% Hold ~22 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ClarissaLove
ClarissaLove Jul. 8 at 5:09 PM
0 · Reply
Alex1965
Alex1965 Jul. 8 at 3:09 PM
$LFMD FWIW. Long LFMD
0 · Reply
Alex1965
Alex1965 Jul. 8 at 3:06 PM
$LFMD RexMD has over 200K subscribers.
0 · Reply
StockScanners
StockScanners Jul. 4 at 5:11 PM
$LFMD keep watch if this holds above 4.77
0 · Reply
Alex1965
Alex1965 Jul. 2 at 8:16 PM
$LFMD The stock got dumped for days and under $4.00 to July 1st. Now why ??? Think smart money, funds.... Nonsense and baseless comments like this one confuse the less savvy retail investors... Beware !!! "...this stock feels more like it is being bleed to death than actually trying to grow and become profitable now." All LFMD's fundamental metrics are all fine and historic best except revenue growth. And that too will improve markedly over the next 18 months starting in Q3 this year. Remember to perform your own DD. PS New exclusive deals getting signed before calendar year ends. a Stronger moat and a very different business model from the rest of the peers.
0 · Reply
prismmarketview
prismmarketview Jul. 2 at 4:11 PM
PRISM Mid-Day Movers: Weight Loss and Biotech are Today’s Leaders. Allurion Technologies Inc. (OTC: $ALUR) is ripping higher again today, with the stock up about 36%to 4.00 from a prior close of 2.94. Chemomab Therapeutics Ltd. (NASDAQ: $CMMB ) is having a strong session, with the stock up about 32% to 2.2401 from a prior close of 1.70. Other Notable Movers: DarioHealth Corp. ($DRIO ) up 13% LifeMD inc. ( $LFMD ) up 10% Aspira Women’s Health ( $AWH) down -15% https://prismmarketview.com/prism-mid-day-movers-weight-loss-and-biotech-are-todays-leaders-2/
0 · Reply
Alex1965
Alex1965 Jul. 2 at 1:53 PM
$LFMD Where is it going so fast ???
0 · Reply
Alex1965
Alex1965 Jul. 1 at 3:45 PM
$LFMD https://www.lilly.com/lillydirect/medicare#overview
0 · Reply
ClarissaLove
ClarissaLove Jul. 1 at 7:13 AM
$LFMD I bet you’re good at picking stocks that require lots and lots of “patience.”
0 · Reply
MarioAndretti
MarioAndretti Jun. 30 at 12:56 AM
$LFMD impatient fucks
2 · Reply
thejman1
thejman1 Jun. 29 at 2:56 PM
$LFMD this stock feels more like it is being bleed to death than actually trying to grow and become profitable now.
0 · Reply
Alex1965
Alex1965 Jun. 28 at 3:21 AM
$LFMD https://seekingalpha.com/news/4607683-medicare-glp-1-bridge-what-to-expect?utm_content=link-3&position=rta_news_sublogic_pretestlaunch_main_2_textlink&utm_source=seeking_alpha&utm_campaign=rta-stock-news&messageid=2900&mailingid=46328155&serial=46328155.3339&utm_term=46328155.3339&source=email_2900&utm_medium=email
0 · Reply
IndependentWatch5
IndependentWatch5 Jun. 26 at 8:07 PM
$LFMD this has been an awful buy
1 · Reply
Phil1973
Phil1973 Jun. 26 at 7:33 PM
$LFMD this is now a 100% “show me” stock. Won’t trade on press releases and hope - just actual results.
1 · Reply
alphawolftrading
alphawolftrading Jun. 23 at 10:21 PM
$LFMD I just sat down again with LifeMD (NASDAQ: LFMD) Co‑Founder & CEO Justin Schreiber for a deep dive into how they’re building a full‑stack virtual healthcare and pharmacy platform – not just a GLP‑1 story. We cover their revamped leadership team, the LifeMD+ $19/month membership model for 24/7 primary and urgent care, upcoming Medicare GLP‑1 access at a $50 copay, and how AI, women’s and men’s health, metabolic programs, and personalized compounding fit into LifeMD’s next phase of growth. https://youtu.be/SfvC-JAFO4M
3 · Reply
ClarissaLove
ClarissaLove Jun. 22 at 9:36 PM
$LFMD Back to the 3s like it never left. Does anyone here have a legitimate bull case that they can kindly share ?
2 · Reply
ClarissaLove
ClarissaLove Jun. 22 at 2:09 PM
0 · Reply